Since FBW7 is an F-box protein that promotes substrate recognition by E3 ligase complex followed by the ubiquitination and degradation [22], it is reasonable to postulate that EglN2 may act as a potential substrate of the FBW7 E3 ligase complex in breast cancer. Here, EGLN2 is linked to breast cancer.